Beste Atelokardie Kinderherzchirurgen - TOP-117 Ärzte

Professor Daniel Zimpfer ist ein hochqualifizierter Herz- und Gefäßchirurg mit einem MBA in Health der WU Wien und einem Chirurgieprogramm der Harvard Medical School. Er ist Leiter der Klinik für Chirurgie angeborener Herzfehler und Mitglied verschiedener nationaler und internationaler Gesellschaften und Zeitschriften auf dem Gebiet der Herz- und Gefäßchirurgie.

Doktor mit einem Abschluss in Medizin und Chirurgie der Universität Complutense Madrid und einer Spezialisierung auf Herz- und Gefäßchirurgie der Autonomen Universität Madrid. Hat Erfahrung in der Kinderherzchirurgie in verschiedenen Krankenhäusern in Spanien und den USA und hat mehr als 100 Artikel in internationalen und nationalen Fachzeitschriften veröffentlicht.

Dr. Sangiorgi graduated in Medicine and Surgery in 1990 from the University of Rome “Tor Vergata”.

He then specialized in Cardiology  at the same University in 1990. He held the role of  Fellow in Interventional Cardiology  and  Research  Associate  at the Haemodynamics Laboratory of the Mayo Clinic and Foundation in Rochester (USA) from 1991 to 1998.

Back in Italy, he became Assistant at the Cardiovascular Interventional Radiology Laboratory of the San Donato Polyclinic Institute from 1998 to 2002, while from 2003 to 2009 he was Co-Director at the Columbus Heart Center and the Hemodynamics Laboratory of the San Raffaele Hospital in Milan. Between 2009 and 2011 he worked as Head of the Hemodynamics Laboratory of the Modena Polyclinic, while in the following three years he worked at the Casilino Polyclinic  in Rome. Since 2014 he has been part of the GVM group and works at various private and accredited facilities throughout the country. Dr. Sangiorgi has been a confirmed Researcher  since 1998, and in 2010 he obtained the qualification to Associate Professor of Cardiology  at the University of Padua.  He is  Professor of Cardiovascular Pathology  at the School of Specialization in Pathological Anatomy of the University of Tor Vergata and Contract Professor for the Peripheral Interventional Course at the Department of Vascular Surgery of the University of Sassari.  He is  also the author of  270 works in national and international journals, 50 book chapters and approximately 900  abstracts . 

Education and Training

• Degree in Medicine and Surgery at the University of Rome Tor Vergata on 07/25/90
• Specialization in Cardiovascular Diseases at the University of Rome Tor Vergata on 01/07/94
• Specialization in Pathological Anatomy at the University of Rome Tor Vergata on 01/10/99
• Enrolled in the Master in Aesthetic Medicine at the University of Rome Tor Vergata for the academic year 2015/2016

Associations and Scientific Societies

• Fellow of the Italian Society of Cardiology (SIC)
• Fellow of the European Society of Cardiology (ESC)
• Fellow of the Italian Society of Interventional Cardiology (SICI-GISE)
• Fellow of the American Society of Interventional Angiography (SCAI)
• Honorary Member of the Romanian Society of Cardiology

Scientific Activity

Dr. Sangiorgi's scientific activity mainly concerns the pathology and physiopathology of the cardiovascular system, with particular reference to coronary and carotid atherosclerotic disease and restenosis after interventional procedures. Furthermore, Dr. Sangiorgi has constantly dealt with issues related to interventional cardiology with particular reference to the medium and long-term results of the use of various platforms of implantable medical devices.

In carrying out these activities he used anatomo-pathological, histochemical and ultrastructural methods. He also dedicated himself particularly to morphometric techniques applied to cardiovascular pathology.

Since September 1993 he has had the opportunity to dedicate himself, at the Mayo Clinic in Rochester (USA), in the Laboratory of Experimental Interventional Cardiology directed by Dr. Robert Schwartz, to the study of the morphology, physiopathology and pathology of restenosis and vascular remodeling mechanical revascularization interventions.

His research focuses on the following main themes:

• Application of morphometric techniques to experimental and human cardiovascular pathology

The research carried out mainly concerned the development of new methods:

1. for the evaluation of smooth muscle cells in the arterial wall during hypertension
2. for the evaluation of the optical density of histological preparations and tissues and for the morphometric evaluation of the size and shape of the nucleus using image analyzers
3. for the evaluation of the cell population of human atherosclerotic plaque by flow cytometry
4. on the application of quantitative immunohistochemical techniques

• Studies on the morphology and pathology of coronary and carotid atherosclerotic disease

In particular, his studies concerned:

1. Experimental atherosclerosis of the coronary arteries of pigs
2. the study of human atheromatous lesions and the relationship between calcific plaque assessed by computed tomography (EBCT) and critical coronary stenoses studied with histological, autoradiographic and morphological methods
3. Morphological study of chronic occlusive coronary lesions in humans
4. Study of the remodeling of human coronary arteries after percutaneous transluminal coronary angioplasty and stent implantation
5. Pathogenetic mechanisms of vascular restenosis after interventional procedures
6. the correlation between the morphological aspects of the human fibroatheroma plaque and the various risk factors
7. Thrombophilia in patients with solid tumors and acute coronary syndromes

• Studies on programmed cell death (apoptosis) in experimental and human atherosclerosis  with immunohistochemical methods and molecular biology techniques
• Studies on the expression of metalloproteinases in human coronary atherosclerosis and aortic diseases  with immunoenzymatic, immunohistochemical and molecular biology methods
• Studies in interventional cardiology  and in particular on the short- and long-term results of implantable medical devices in the coronary and peripheral areas both in spontaneous studies and in randomized trials

Dr. Giuseppe Sangiorgi has also participated in the following Research Projects in competition of the National Research Center, National Committee for Biological and Medical Sciences:

• Effect of myocardial revascularization by PTCA on global and segmental left ventricular function in patients with severe coronary artery disease and severely dysfunctional left ventricle.; September 1993- August 1996
• Study on the extent and location of calcium accumulation in samples of pathological human coronary arteries correlating morphometric aspects with images obtained by tomographic method; May 1994- August 1995.

 Professional Assignments

• From February 1998 to January 2003 he carried out his healthcare and research activities as an assistant at the Hemodynamics Laboratory of the San Donato Polyclinic Institute, directed by Prof. Luigi Inglese.
• Since September 1998 he has held the position of Researcher at the Department of Internal Medicine of the II University of Rome “Tor Vergata” for the disciplinary sector MED/11 Diseases of the Cardiovascular System. Since December 2002 he has been a confirmed Researcher at the Chair of Diseases of the Cardiovascular System of the II University of Rome Tor Vergata. He has held a position for healthcare purposes since 2.5.2007 at the AFA of Medicine – Discipline of Cardiology at the Policlinico Tor Vergata.
• From January 2003 to February 2009 he was assistant with the qualification of Associate Director of the Hemodynamics Laboratory of the Columbus Clinic and the San Raffaele Hospital in Milan. At the moment he has more than 7000 coronary interventional procedures and 3500 peripheral procedures as first operator.
• Since 2007 he has been responsible for the Cardiovascular Pathological Anatomy course at the School of Specialization in Pathological Anatomy of the University of Rome Tor Vergata
• He was responsible for the course of Hemodynamics and Interventional Cardiology at the School of Specialization in Cardiology of the University of Rome Tor Vergata for the academic years 2004-2005, 2005-2006, 2006-2007 and for the course in Cardiovascular Diseases for the School of Specialization in Sports Medicine for the academic year 2006-2007.
• From 2005 to 2009 he was scientific director and teacher of the Master in Interventional Cardiology at the Vita e Salute University of San Raffaele in Milan and head of the peripheral program of the haemodynamics laboratory of the San Raffaele Hospital
• From February 2009 to April 2011 he was responsible for the Haemodynamics Laboratory of the Modena Polyclinic and Director of the Master in Interventional Cardiology
• From 2011 to 2013 he carried out assistance activities at the Hemodynamics Laboratory of the Casilino Polyclinic – Rome
• From 2013 to today he has carried out healthcare activities in the Villa Maria group and in particular in the facilities of Rome (Private Nursing Home), Florence (SSN accredited) and Cotignola (SSN accredited)

Research Activities Abroad

• In the summer of 1989, having won a scholarship abroad, offered by the European Community within the framework of the ERASMUS programme, he attended for four months as a medical student the Department of Clinical Pharmacology and Therapeutics of the Charring Cross and Westminster Medical School in London (UK).
• Since September 1993, having won a grant for other interventions from the National Research Council, he spent the last year of the specialization course at the Department of Internal Medicine and Cardiovascular Diseases of the Mayo Clinic in Rochester, Minnesota (USA), where he carried out research activities under the direction of Dr. Robert Schwartz with the qualification of Research fellow.
• In March 1994, he was awarded a grant for other interventions by the National Research Council, which allowed him to continue his research at the Laboratory of Experimental Interventional Cardiology under the direction of Dr. Robert S. Schwartz as a research fellow.
• From October 1995 to today he has worked and continues to collaborate with the Interventional Cardiology laboratory of the Mayo Clinic in Rochester, with the qualification of “Research Associate” under the direction of Dr. David R. Holmes Jr.

Scientific Awards and Recognitions

• Finalist for Outstanding Investigator of the American Society of Atherosclerosis, Thrombosis and Vascular Biology (1996)
• 3rd American Heart Association Outstanding Researcher Award (1998)
• 1st Prize Best Researcher Italian Society of Cardiology (2001)

Editorial and Corporate Assignments

• From 2005 to 2009 he was a member of the Board of Directors of the Italian Society of Interventional Cardiology and from 2006 to 2015 he was Vice President of the GISE Foundation.
• Since 1999 he has been a member of the editorial and editorial committee of the Italian Medical Encyclopedia
• Since October 2003 he has been Associate Editor of the journal Cardiology International
• Since June 2005 he has been Associate Editor of the journal Cardiovascular Revascularization Medicine
• Since January 2008 he has been a member of the Editorial Board of the Journal of the American College of Cardiology Imaging and of the Journal of Endovascular Therapy, of the Journal of the Italian Society of Interventional Cardiology.
• He is an anonymous reviewer of the major international Cardiology journals.
• He was the lead editor of the book “Carotid Atherosclerotic Disease: Pathologic Basis for treatment” published by Informa Health Care in February 2008

 Awards and Recognitions

In 1998 he received the third prize as “ Young Researcher ” from the American Heart Association  for the discovery  of cellular apoptosis in aortic valves  in patients affected by aortic stenosis and the first prize from the  Italian Society of Cardiology  as “Young Researcher” for the discovery of a  new serum marker for the risk of STROKE  in December 2001.

• Spezialisiert auf die Behandlung von Atelokardie durch chirurgische Korrekturen, kathetergestützte Eingriffe und medikamentöse Behandlung.
• Hat Erfahrung in Kliniken und medizinischen Einrichtungen in der Türkei, Italien und den USA.
• Veröffentlichte zahlreiche Artikel über herzchirurgische Techniken und Ergebnisse in renommierten Fachzeitschriften.
• Mitglied der European Association for Cardio-Thoracic Surgery (EACTS) und der Turkish Society of Cardiovascular Surgery.
• Spricht fließend Englisch und Türkisch, was eine effektive Kommunikation mit Patienten unterschiedlicher Herkunft ermöglicht.

Dr. Sandeep Attawar ist ein berühmter Herz-Thorax-Chirurg in Indien. Dient als Direktor des Programms für Herzchirurgie und thorakale Organtransplantation in Gleneagles Global Health City.

Spezialität

Dr. Sandeep Attawar ist Spezialist für Herz-Thorax-Chirurgie. Er hat an über 10.000 Operationen am offenen und geschlossenen Herzen bei Erwachsenen und Kindern teilgenommen.

Seine Expertise umfasst auch Herz- und Lungentransplantationen mit einer Erfolgsquote von 85-90 %.

Berufserfahrung

• Seit 2017 – Direktor & Vorsitzender des Programms für Herz-Kreislauf-Chirurgie, thorakale Organtransplantation und MCS-Programm am Global Hospital Chennai (Gleneagles Global Health City)
• 2013-2017 – Leiter der Abteilung für Herzchirurgie, mechanische Kreislaufunterstützung, Herztransplantation am Fortis Gurgaon Memorial Research Institute
• 2012-2013 – Direktor für Herzchirurgie und Thorax-Organtransplantation bei der Global Hospitals Group in Chennai
• 2010-2012 – Vizepräsident und Direktor des Zentrums für Herzwissenschaften bei Narayana Health in Jaipur
• 2005-2010 – Leitender Herzchirurg und Leiter der kardiochirurgischen Abteilung bei Apollo Dhaka
• 2003-2005 – Chefarzt für Herzchirurgie am Rabindranath Tagore International Institute of Cardiac Sciences in Kalkutta
• 2000-2002 – Herzchirurg am Cardiac AJ Hospital and Research Center in Mangalore, Manipal Heart Foundation in Bangalore und Narayana Hrudayalaya in Bangalore.

Bildung

• The Medical Faculty Sree Chitra Tirunal Institute for Medical Sciences & Technology – Abschluss in Allgemeinmedizin, Fachrichtung Allgemeinchirurgie, Fachrichtung Herz-Thorax-Chirurgie.

Mitgliedschaft in Organisationen

• Die Internationale Gesellschaft für minimalinvasive kardiothorakale Chirurgie
• Die Internationale Gesellschaft für Herz- und Lungentransplantation
• Die minimal invasive Robotik-Vereinigung
• Die Gesellschaft der Thoraxchirurgen
• Die Europäische Gesellschaft für Herz-Thorax-Chirurgie
• Menschliche Grundlage sein.

Dr. Krishna Iyer is one of India's front ranking paediatric cardiac surgeons, recognised for his clinical expertise and wide ranging involvement with cardiac care for children in India and other developing nations, Dr. Iyer initiated the first dedicated paediatric cardiac care program in Northern India , a pioneering initiative, at Escorts Heart Institute Research Centre( now Fortis-Escorts Heart Institute ) in 1995. Under his guidance this paediatric cardiac program has become the benchmark for cardiac care for children for India and its South East Asian neighbours. Dr. Iyer has operated on more than 10,000 babies, children and adults with congenital heart diseases comprising various procedures like arterial switch procedure, double switch operation TAPVC repairs, Fontan and Fontan type procedures, corrections for tetralogy of Fallot, DORV, Truncus etc. Senning operation, conduit repairs and wide range of one stage and multi-stage corrections for complex congenital heart diseases. He has done original work on rapid two-stage arterial switch procedure and performed the first successful rapid two stage arterial switch and double-switch operation in India. His current interests are perfecting complex neonatal cardiac surgery, cardiac surgery in malnourished infants and children, salvaging late presenters of congenital heart disease, and developing cost effective cardiac care for children in developing countries. After basic training, he joined the Department of Cardiothoracic and Vascular Surgery at AIIMS and was Additional Professor at the time he moved to Escorts Heart Institute to set up its paediatric cardiac care division. He trained in paediatric and infant cardiac surgery under the guidance of the renowned paediatric cardiac surgeon Dr. R.B.B.Mee as Senior Fellow at the Department of Paediatric Cardiac Surgery at Royal Children's Hospital, Melbourne in Australia in 1989. He is involved in many charities for underprivileged children, most notably the 'Gift of Life' program of Rotary International.

Kürşat Fidancı is a medical doctor who graduated from GATA Faculty of Medicine in 1999. Between 2000 and 2002, he served as the Chief Physician of the Şırnak Çakırsöğüt Commando Brigade. He completed his residency in Pediatrics from 2002 to 2006 at Istanbul GATA Haydarpaşa Training and Research Hospital. He worked as a Pediatrician at Ankara Beytepe Military Hospital between 2006 and 2009. He completed his subspecialty training in Paediatric Cardiology at GATA Faculty of Medicine Pediatric Cardiology Department from 2010 to 2013. He became an Assistant Professor in 2014 and obtained the title of Associate Professor in April 2016. He worked as a faculty member in the Department of Pediatric Cardiology at GATA Faculty of Medicine between September 2014 and December 2021. As a pediatric cardiologist, Dr. Kürşat Fidancı has seen numerous patients and his medical interests include Fetal Echocardiography, Congenital Heart Diseases, Rheumatic Heart Diseases, Rhythm Disorders, and Athlete's Heart Health and Follow-up.

Treatments: 

Minimally invasive surgery, microsurgery Experience: 2019-2021, Academician at Pediatric Surgery Division, 

Ankara City Hospital- Children's Hospital 2012-2019, Surgical Education Lecturer,Diskapi Children's Hospital 2004-2012, Physician, Diskapi Children's Hospital

 Education: 2001 Pediatric Surgery Clinic, Dr Sami Ulus Children's Hospital 1993-1994, Washington University Medical School, St. Louis, Mo, the U.S.A. 1989 School of Medicine, Ondokuz Mayıs University Scientific Studies: 49 articles published in international peer-review journals. 106 papers presented at international and national scientific meetings and published in proceedings 16 lectures in international and national congresses Reviewer in 11 international and national journals

Herzchirurg. Spezialisiert auf minimal-invasive Operationen am Herzen.

Leiter der Abteilung Kinderherztransplantation, Herzchirurg

Herzchirurg, Spezialist für angeborene Herzfehler

• Dr. Felix Berger ist auf die Behandlung von Atelokardien spezialisiert und verfügt über mehr als 34 Jahre Erfahrung in der Kinderkardiologie.
• Er wendet fortschrittliche Methoden an, darunter chirurgische Korrekturen, kathetergestützte Eingriffe, medikamentöse Behandlung und Änderungen der Lebensweise.
• Er hat eine internationale Ausbildung in Deutschland und der Schweiz absolviert und verfügt über umfangreiche Erfahrung in medizinischen Einrichtungen in Berlin, Deutschland.
• Er ist Mitglied der Deutschen Gesellschaft für Pädiatrische Kardiologie, der Schweizerischen Gesellschaft für Pädiatrische Kardiologie und der Europäischen Gesellschaft für Kardiologie.
• Er promovierte 1991 an der Universität Berlin und 2003 an der Universität Zürich.

Dr. X ist Mitglied der European Association of Cardiothoracic Surgeons (EACTS) und der Association of Cardiovascular Surgeons of Ukraine (ACSU). Er ist außerdem Autor von über 100 wissenschaftlichen Publikationen, die in den führenden European Journals of Cardiac Surgery (EJCS) veröffentlicht wurden.